 Multiple IRF7 transcript variants have been identified, although the functional consequences of these have not yet been established.The IRF7 pathway was shown to be silenced in some metastatic breast cancer cell lines, which may help the cells avoid the host immune response.Restoring IRF7 to these cell lines reduced metastases and increased host survival time in animal models.